PFIZER-BIONTECH COVID-19 VACCINE 95% EFFECTIVE IN FINAL TRIAL

© Provided by dw.com Final results for the coronavirus vaccine developed by US-based Pfizer and German partner BioNTech showed its shot had a 95% efficacy rate, the two pharmaceutical firms said on Wednesday, with the trials also providing a two-months worth of data on vaccine's safety. The latest results came at the conclusion of phase-three testing of the vaccine. The two companies a...